Table 1.

Characteristics of eligible studies

First author (publication year)	Study design	Study region	Sample size	Specimen type	Enterococci prevalence, N (%)	Enterococcus species isolated	AST method	Prevalence of VRE (%)
Adesida (2017)	CS	South-west, Western region	100	Stool	73 (73.0)	E feacalis E faecium	Disk diffusion	9 (13.80)
Ekuma (2016)	CS	South-west, Western region	319	Rectal swabs	13 (4.07)	E faecium, E gallinarum, E casseliflavus	Dilution/MIC, PCR	13 (4.07)
Ezeah (2019)	CS	South-east, Eastern region	1048	Urine, sputum, stool, aspirates, CSF, high vaginal swab, urethral, wound Nasa, ear and anal	68 (6.49)	E faecalis and E avium	Disk diffusion Method	21 (30.90)
Kunurya (2020)	CS	North-west, Northern region	114	Urine	8 (7.00)	E faecalis	Kirby Bauer Disk diffusion Method, and MIC	4 (50.00)
Ndubuisi (2017)	CS	North-central, Northern region	500	Stool, urine, wound swab, Environmental samples	102 (24.00)	E faecalis E faecium, E Casseliflavus, E mundtii, E dispar, E shirae, E avium E gallinarum	Kirby Bauer Disk diffusion Method	34 (33.33)
Olawale (2011)	CS	South-west, Western region	118	Blood, urine, wound swabs, sputum, and stool	7 (5.90)	E faecalis E faecium	Disk diffusion	3 (42.90)
Shettima (2019)	CS	North-east, Northern region	561	stool	561 (100%)	E faecalis, E faecium, E casseliflavus, E hirae, E durans, E mundtii, E raffinosus, E dispar	Dilution/MIC	6 (0.01)

AST = antibiotic susceptibility testing; VRE = vancomycin-resistant enterococci.